CD155 expression positively correlated with TIGIT (p < 0.001, Figure 4F), and the proportion of TIGIT-positive patients tended to increase with advanced tumor size, T stage, distant metastasis, and TNM stage (Table 2, Figures 4G–J). Here, TIGIT is linked to neoplasm.